Brenden Ingraham, M.D.
@brendeningraham
Assistant Professor @MayoClinicCV • Coronary/Peripheral Intervention • High Bleed Risk PCI • @MayoMN_IMRES @USACollegeofMed • Tweets are mine
ID: 1220441020183339013
23-01-2020 20:20:18
202 Tweet
624 Followers
462 Following
mandeep singh presents our findings from the CHAMP Trial. #Genotype-guided P2Y12 inhibitor monotherapy within a week of #PCI is feasible and likely safe in patients with #HBR. Rajiv Gulati Chet Rihal Amir Lerman Naveen Pereira Linnea Baudhuin, PhD 🧬 Ann Moyer #ACC2024 🫀🩸
